Pictet Asset Management
RCUS icon

Pictet Asset Management’s Arcus Biosciences RCUS Stock Holding History

Pictet Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Hold
11,462
– – ﹤0.01% 1824
2025
Q4 		$273K Buy
+11,462
New +$234K ﹤0.01% 1758
2025
Q2 		– Sell
-10,452
Closed -$82K – 2046
2025
Q1 		$82K Buy
+10,452
New +$121K ﹤0.01% 1959
2024
Q1 		– Sell
-355,143
Closed -$6.78M – 2017
2023
Q4 		$6.78M Buy
355,143
+9,549
+3% +$153K 0.01% 736
2023
Q3 		$6.2M Buy
+345,594
New +$6.94M 0.01% 727

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Pictet Asset Management's RCUS Position: Q1 2026 in Review

Pictet Asset Management held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 11,462 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Pictet Asset Management first reported a position in RCUS in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.78M in Q4 2023. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Pictet Asset Management held 11,462 shares of Arcus Biosciences worth $248K as of Q1 2026.
  • Pictet Asset Management left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1824 holding.
  • Pictet Asset Management first reported a position in Arcus Biosciences in Q3 2023 and has held it in 5 quarters since.
  • Pictet Asset Management's Arcus Biosciences position peaked at $6.78M in Q4 2023.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.